Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-19-005127
Filing Date
2019-07-16
Accepted
2019-07-16 20:31:43
Documents
2
Period of Report
2019-07-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1600
2 POWER OF ATTORNEY ex24.htm EX-24 8594
  Complete submission text file 0001387131-19-005127.txt   11797
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2235 VIA FRESCA LA JOLLA CA 92037
Business Address
Miralles Gines Diego (Reporting) CIK: 0001773413 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35963 | Film No.: 19958101